Diabetes:
Indications for ZEGALOGUE:
Severe hypoglycemia.
Adults and Children:
<6yrs: not established. Give by SC inj into lower abdomen, buttocks, thighs, or outer upper arm. ≥6yrs: 0.6mg. May repeat if no response after 15mins. After responding, give oral carbohydrates.
ZEGALOGUE Contraindications:
Pheochromocytoma. Insulinoma.
ZEGALOGUE Warnings/Precautions:
Instruct caregivers in proper use. Previously undiagnosed pheochromocytoma. Lack of efficacy in insulinoma; may cause hypoglycemia. If hypoglycemia develops after treatment, give oral or IV glucose. Insufficient hepatic glycogen reserves (eg, starvation, adrenal insufficiency, chronic hypoglycemia); treat with glucose. Pregnancy. Nursing mothers.
ZEGALOGUE Classification:
Antihypoglycemic.
ZEGALOGUE Interactions:
Transient increase in pulse and blood pressure may occur with beta-blockers. Loss of efficacy or may produce hypoglycemia with indomethacin. May potentiate the anticoagulant effect of warfarin.
Adverse Reactions:
Nausea, vomiting, headache, inj site pain; adults also: diarrhea; hypersensitivity reactions.
Generic Drug Availability:
NO
How Supplied:
Single-dose prefilled syringe, single-dose autoinjector—1, 2
